XML 15 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jul. 02, 2017
Jun. 26, 2016
Jul. 02, 2017
Jun. 26, 2016
Revenues $ 19,939 $ 20,371 $ 41,974 $ 41,204
Cost of products sold 13,718 14,471 28,863 28,899
Gross profit 6,221 5,900 13,111 12,305
Operating expenses:        
Research and development 1,185 1,425 2,323 3,081
Selling, general and administrative 3,714 3,976 7,625 8,243
Total operating expenses 4,899 5,401 9,948 11,324
Operating income 1,322 499 3,163 981
Other (expense) income:        
Interest and financing expense (41) (62) (109) (163)
Miscellaneous (8) 38 (33) 26
Income before income taxes 1,273 475 3,021 844
Income tax provision 179 33 266 121
Net income 1,094 442 2,755 723
Net loss (income) attributable to non-controlling interest 4 (6) 22
Net income attributable to Ultralife Corporation 1,094 446 2,749 745
Other comprehensive income (loss):        
Foreign currency translation adjustments 494 (422) 753 (701)
Comprehensive income attributable to Ultralife Corporation $ 1,588 $ 24 $ 3,502 $ 44
Net income per share attributable to Ultralife common shareholders – basic (in dollars per share) $ 0.07 $ 0.03 $ 0.18 $ 0.05
Net income per share attributable to Ultralife common shareholders – diluted (in dollars per share) $ 0.07 $ 0.03 $ 0.17 $ 0.05
Weighted average shares outstanding – basic (in shares) 15,510 15,258 15,461 15,290
Potential common shares (in shares) 340 161 291 255
Weighted average shares outstanding - diluted (in shares) 15,850 15,419 15,752 15,545